Home >> Pharmaceuticals >> Food & Beverage >>

Global Biosimilar Drug Market Report 2019 - Industry Analysis Size Share Trends Segment and Forecasts to 2025

Published: Nov-2019 | Format: PDF | MAResearch | Number of pages: 105 | Code: MRS - 675512

The global Biosimilar Drug market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Biosimilar Drug from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biosimilar Drug market.

Leading players of Biosimilar Drug including:
    Amgen
    Eli Lilly
    Novartis
    CP Guojian Pharma
    Biotech Pharma
    ...

Market split by Type, can be divided into:
    Injection
    Tablets
    Other Types

Market split by Application, can be divided into:
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular
    Other Application

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Biosimilar Drug Market Overview
    1.1 Biosimilar Drug Definition
    1.2 Global Biosimilar Drug Market Size Status and Outlook (2013-2028)
    1.3 Global Biosimilar Drug Market Size Comparison by Region (2013-2028)
    1.4 Global Biosimilar Drug Market Size Comparison by Type (2013-2028)
    1.5 Global Biosimilar Drug Market Size Comparison by Application (2013-2028)
    1.6 Global Biosimilar Drug Market Size Comparison by Sales Channel (2013-2028)
    1.7 Biosimilar Drug Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Biosimilar Drug Market Segment Analysis by Player
    2.1 Global Biosimilar Drug Sales and Market Share by Player (2016-2018)
    2.2 Global Biosimilar Drug Revenue and Market Share by Player (2016-2018)
    2.3 Global Biosimilar Drug Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Biosimilar Drug Market Segment Analysis by Type
    3.1 Global Biosimilar Drug Market by Type
        3.1.1 Injection
        3.1.2 Tablets
        3.1.3 Other Types
    3.2 Global Biosimilar Drug Sales and Market Share by Type (2013-2018)
    3.3 Global Biosimilar Drug Revenue and Market Share by Type (2013-2018)
    3.4 Global Biosimilar Drug Average Price by Type (2013-2018)
    3.5 Leading Players of Biosimilar Drug by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 Biosimilar Drug Market Segment Analysis by Application
    4.1 Global Biosimilar Drug Market by Application
        4.1.1 Ankylosing Spondylitis
        4.1.2 Tumor
        4.1.3 Rheumatoid Arthrtis
        4.1.4 Cardiovascular
        4.1.5 Other Application
    4.2 Global Biosimilar Drug Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Biosimilar Drug by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 Biosimilar Drug Market Segment Analysis by Sales Channel
    5.1 Global Biosimilar Drug Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Biosimilar Drug Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Biosimilar Drug by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biosimilar Drug Market Segment Analysis by Region
    6.1 Global Biosimilar Drug Market Size and CAGR by Region (2013-2028)
    6.2 Global Biosimilar Drug Sales and Market Share by Region (2013-2018)
    6.3 Global Biosimilar Drug Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Biosimilar Drug Market Share by Type
        6.4.3 North America Biosimilar Drug Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Biosimilar Drug Market Share by Type
        6.5.3 Europe Biosimilar Drug Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Biosimilar Drug Market Share by Type
        6.6.3 Asia-Pacific Biosimilar Drug Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Biosimilar Drug Market Share by Type
        6.7.3 South America Biosimilar Drug Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Biosimilar Drug Market Share by Type
        6.8.3 Middle East & Africa Biosimilar Drug Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biosimilar Drug Players
    7.1 Amgen
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Eli Lilly
    7.3 Novartis
    7.4 CP Guojian Pharma
    7.5 Biotech Pharma
Chapter 8 Upstream and Downstream Analysis of Biosimilar Drug
    8.1 Industrial Chain of Biosimilar Drug
    8.2 Upstream of Biosimilar Drug
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Biosimilar Drug
        8.3.1 Leading Distributors/Dealers of Biosimilar Drug
        8.3.2 Leading Consumers of Biosimilar Drug
Chapter 9 Development Trend of Biosimilar Drug (2019-2028)
    9.1 Global Biosimilar Drug Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Biosimilar Drug Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Biosimilar Drug Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Biosimilar Drug Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Biosimilar Drug Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)2500 View Pricing